Search

everythinglearnresearchcommunity

for

Search:↓

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Birth control pills can cause skin issues but may help with acne and hirsutism, and choosing the right type can minimize side effects.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

High proliferative activity and peripheral invasion indicate malignancy in canine sebaceous gland tumors; the term 'epithelioma' should be updated for clarity.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Dosing time affects finasteride's effectiveness and safety in rats.

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Hair loss needs more research for better treatments.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.